Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research, 27659 [2019-12503]
Download as PDF
<![CDATA[
27659
Federal Register / Vol. 84, No. 114 / Thursday, June 13, 2019 / Notices
comments or objections were submitted
for the notice.
Company
FR docket
Navinta, LLC ...............
84 FR 5498
Published
February 21, 2019.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic class
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: June 3, 2019.
John J. Martin,
Assistant Administrator.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
[FR Doc. 2019–12504 Filed 6–12–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research
ACTION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 12, 2019.
DATES:
Notice of application.
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 7, 2019, Sigma
Aldrich Research, Biochemicals, Inc.,
400–600 Summit Drive, Burlington,
Massachusetts 01803 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Alpha-methyltryptamine ...................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .............................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) .................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
khammond on DSKBBV9HB2PROD with NOTICES
The company plans to manufacture
reference standards.
Dated: June 3, 2019.
John J. Martin,
Assistant Administrator.
BILLING CODE 4410–09–P
16:55 Jun 12, 2019
Drug Enforcement Administration
[Docket No. 18–29]
[FR Doc. 2019–12503 Filed 6–12–19; 8:45 am]
VerDate Sep<11>2014
DEPARTMENT OF JUSTICE
Elizabeth C. Korcz, M.D.; Decision and
Order
On March 28, 2018, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA or
Jkt 247001
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
1235
1248
7315
7370
7405
7432
7435
7439
7493
7517
7535
7540
9200
9313
9634
1100
7379
7471
9041
9050
9180
9220
9230
9250
9300
9333
9648
9668
9739
9740
9743
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Government), issued an Order to Show
Cause (hereinafter, OSC) to Elizabeth C.
Korcz, M.D. (hereinafter, Respondent),
who is registered in Hoover, Alabama.
The OSC proposed to revoke
Respondent’s DEA Certificate of
Registration (hereinafter, COR) No.
FK0505428, pursuant to 21 U.S.C.
§§ 823(f) and 824(a)(3), on the ground
that she does not have authority to
handle controlled substances in
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 84, Number 114 (Thursday, June 13, 2019)]
[Notices]
[Page 27659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12503]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Sigma
Aldrich Research
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before August 12, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 7, 2019, Sigma Aldrich Research, Biochemicals,
Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803 applied to
be registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................ 1235 I
Mephedrone (4-Methyl-N-methylcathinone).. 1248 I
Lysergic acid diethylamide............... 7315 I
Tetrahydrocannabinols.................... 7370 I
3,4-Methylenedioxymethamphetamine........ 7405 I
Alpha-methyltryptamine................... 7432 I
Dimethyltryptamine....................... 7435 I
5-Methoxy-N,N-diisopropyltryptamine...... 7439 I
N-Benzylpiperazine....................... 7493 I
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) 7517 I
MDPV (3,4-Methylenedioxypyrovalerone).... 7535 I
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Heroin................................... 9200 I
Normorphine.............................. 9313 I
Norlevorphanol........................... 9634 I
Amphetamine.............................. 1100 II
Nabilone................................. 7379 II
Phencyclidine............................ 7471 II
Cocaine.................................. 9041 II
Codeine.................................. 9050 II
Ecgonine................................. 9180 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Methadone................................ 9250 II
Morphine................................. 9300 II
Thebaine................................. 9333 II
Levo-alphacetylmethadol.................. 9648 II
Noroxymorphone........................... 9668 II
Remifentanil............................. 9739 II
Sufentanil............................... 9740 II
Carfentanil.............................. 9743 II
Fentanyl................................. 9801 II
------------------------------------------------------------------------
The company plans to manufacture reference standards.
Dated: June 3, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-12503 Filed 6-12-19; 8:45 am]
BILLING CODE 4410-09-P
